Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Optimization of Lyophilized Hyperacute Serum (HAS) as a Regenerative Therapeutic in Osteoarthritis.

Autor: Olmos Calvo I; OrthoSera GmbH, Dr. Karl-Dorrek-Straße 23-29, 3500 Krems an der Donau, Austria., Kuten-Pella O; OrthoSera GmbH, Dr. Karl-Dorrek-Straße 23-29, 3500 Krems an der Donau, Austria., Kramer K; Center for Regenerative Medicine, Danube University of Krems, 3500 Krems an der Donau, Austria., Madár Á; OrthoSera GmbH, Dr. Karl-Dorrek-Straße 23-29, 3500 Krems an der Donau, Austria., Takács S; OrthoSera GmbH, Dr. Karl-Dorrek-Straße 23-29, 3500 Krems an der Donau, Austria., Kardos D; Research Center for Natural Sciences, 1117 Budapest, Hungary., Simon D; Department of Immunology and Biotechnology, Medical School, University of Pécs, 7624 Pécs, Hungary., Erdö-Bonyár S; Department of Immunology and Biotechnology, Medical School, University of Pécs, 7624 Pécs, Hungary., Berki T; Department of Immunology and Biotechnology, Medical School, University of Pécs, 7624 Pécs, Hungary., De Luna A; Center for Regenerative Medicine, Danube University of Krems, 3500 Krems an der Donau, Austria., Nehrer S; Center for Regenerative Medicine, Danube University of Krems, 3500 Krems an der Donau, Austria., Lacza Z; Department of Sport Physiology, University of Physical Education, 1123 Budapest, Hungary.; Institute of Translational Medicine, Semmelweis University, 1085 Budapest, Hungary.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Jul 13; Vol. 22 (14). Date of Electronic Publication: 2021 Jul 13.